Purpose: To test the hypothesis that the pathogenicity of distinct SYNGAP1 variants found in patients will correlate with the extent of dysfunction in neurons derived from their own cells.
Funding: $205,500 over three years to support the training of a postdoctoral researcher.
Key people: Gavin Rumbaugh, Ph.D. & Nerea Llamosas PhD
Status: Approved, Signed, 100% disbursed.